Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

Bibliographic Details
Main Authors: Samuel Bitoun, Xavier Mariette, Jerome Avouac, Raphaele Seror, Gaetane Nocturne, Flore Rozenberg, Julien Henry, Rakiba Belkhir, Omar Al Tabaa, Roba Ghossan, Alice Andrée Mariaggi, Christelle Vauloup-Fellous
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/1/e002308.full